Merck and Daiichi withdraw their small-cell lung cancer drug bid after FDA signals Phase 2 data fell short of accelerated approval requirements

Hello! It looks like you're interested in this conversation, but you don't have an account yet.

Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

With your input, this post could be even better 💗